Skip to main content
Clinical Trials/NCT06190613
NCT06190613
Recruiting
N/A

Adapting and Testing a Combination Peer Navigation and MHealth Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria

Northwestern University1 site in 1 country100 target enrollmentNovember 28, 2024
ConditionsHIV

Overview

Phase
N/A
Intervention
Not specified
Conditions
HIV
Sponsor
Northwestern University
Enrollment
100
Locations
1
Primary Endpoint
HIV viral load suppression
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.

Detailed Description

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among young men who have sex with men (YMSM) and young transgender women (YTW), ages 15-29. The 24-week pilot study will randomize participants at a ratio of 1:1 to the intervention or control. The goals of the pilot study are to assess: a) whether the intervention worked as intended (initial efficacy); and b) the feasibility, satisfaction, and acceptability among the target population of YMSM and YTW receiving HIV care in the community setting. Specific aims are to: 1. Adapt the iCARE Nigeria HIV clinic-based intervention to a community-based outreach approach for YMSM and YTW ages 15-29 in Ibadan, Nigeria. This process will be structured using best practices for adaptation of evidence-based intervention, including distillation of adaptable components and incorporation of feedback from stakeholders, following user-centered principles of iterative design. 2. In a randomized controlled trial, test the adapted iCARE intervention for initial efficacy, feasibility, satisfaction, and acceptability among YMSM and YTW in the key population (KP)-focused community settings. The primary outcome will be viral load suppression (viral load\<200 copies/mL). Secondary outcomes include antiretroviral drug adherence, and treatment retention via abstraction of medical records. 3. Evaluate implementation indicators based on RE-AIM (reach, adoption, implementation, maintenance) to improve external validity and to inform sustainability and scalability of the adapted iCARE Nigeria intervention. A mixed methods approach will be used to collect data for implementation outcomes from interventionists, intervention participants, and representatives of KP-friendly community centers.

Registry
clinicaltrials.gov
Start Date
November 28, 2024
End Date
August 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lisa Kuhns

Professor

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • HIV seropositive
  • registered as a patient at one of the collaborating key population (KP)-focused community centers
  • male sex at birth
  • identify as YMSM or YTW (or report a history of sex with men)
  • on ART for at least 3 months
  • understand and read basic English, Yoruba, or Pidgin English
  • intention to remain a patient at a collaborating clinic during the 24-week follow-up period
  • has a cellphone

Exclusion Criteria

  • Unable to obtain parental permission if 15 years of age and not emancipated

Outcomes

Primary Outcomes

HIV viral load suppression

Time Frame: Baseline, 24 weeks

Viral load suppression (\<200 copies/mL) at baseline and 24 weeks

Secondary Outcomes

  • Retention in HIV care(Baseline, 24 weeks)
  • Medication adherence(Baseline, 24 weeks)
  • Feasibility of intervention(24 weeks)
  • Acceptability of intervention(24 weeks)

Study Sites (1)

Loading locations...

Similar Trials